M. van Woensel

Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy.

V. Mathieu, K. Amighi, M. Vermeersch, 2016, International journal of pharmaceutics.

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines

S. V. Van Gool, Lien Vandenberk, M. van Woensel, 2016, Front. Immunol..

Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma

L. Boon, P. Agostinis, Marco B. E. Schaaf, 2017, Oncoimmunology.

Tumor Targeting by Peptide-Decorated Gold Nanoparticles.

S. Greco, V. Mathieu, A. Donnadio, 2019, Molecular pharmaceutics.

Histamine and T helper cytokine–driven epithelial barrier dysfunction in allergic rhinitis

P. Hellings, C. Akdis, S. Seys, 2017, The Journal of allergy and clinical immunology.

Clinical‐Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes

C. Verfaillie, D. Bullens, S. V. Van Gool, 2016, Stem cells translational medicine.

New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.

V. Mathieu, K. Amighi, M. Vermeersch, 2018, Molecular pharmaceutics.

Altered galectin-1 serum levels in patients diagnosed with high-grade glioma

R. Kiss, V. Mathieu, S. Fieuws, 2013, Journal of Neuro-Oncology.